HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 59 filers reported holding HERON THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $465,000 | +278.0% | 110,121 | +150.2% | 0.01% | +233.3% |
Q2 2022 | $123,000 | -79.8% | 44,006 | -58.7% | 0.00% | -78.6% |
Q1 2022 | $610,000 | -65.7% | 106,653 | -45.3% | 0.01% | -53.3% |
Q4 2021 | $1,779,000 | +112.3% | 194,874 | +277.0% | 0.03% | +76.5% |
Q1 2021 | $838,000 | -32.2% | 51,690 | -38.5% | 0.02% | -72.1% |
Q2 2020 | $1,236,000 | -16.7% | 84,039 | +2.5% | 0.06% | +60.5% |
Q4 2017 | $1,483,000 | +345.3% | 81,951 | +297.0% | 0.04% | +375.0% |
Q3 2017 | $333,000 | +29.1% | 20,642 | +10.9% | 0.01% | 0.0% |
Q2 2017 | $258,000 | +2.0% | 18,618 | +10.2% | 0.01% | 0.0% |
Q1 2017 | $253,000 | -33.2% | 16,894 | -15.3% | 0.01% | -20.0% |
Q1 2016 | $379,000 | -41.4% | 19,943 | -24.8% | 0.01% | -54.5% |
Q3 2015 | $647,000 | +9.5% | 26,533 | +39.9% | 0.02% | +29.4% |
Q2 2015 | $591,000 | +17.5% | 18,972 | -53.5% | 0.02% | -10.5% |
Q2 2014 | $503,000 | +44.5% | 40,800 | +63.2% | 0.02% | +26.7% |
Q1 2014 | $348,000 | – | 24,999 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $1,900 | 100.00% |
Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
CM Management, LLC | 250,000 | $625 | 0.75% |
Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |